SNY Stock Analysis Today
Updated Nov 15, 2026 · trends, key levels, insider activity and news
Is SNY bullish or bearish today?
Daily trend: Downtrend (confirmed) — turns up above $40.31
SEPT signal: Institutional Drive · Strong Bullish
Research grade: C+ · fair value $71.73
SNY trend by timeframe
| Daily | Downtrend (confirmed) |
|---|---|
| 4 hour | Leaning Bearish |
| 1 hour | Bearish |
| 15 min | Bearish |
| 5 min | Leaning Bearish |
Trends are calculated from price structure and update during market hours.
SNY support and resistance levels
Resistance (above)
$49.428 touches
$50.604 touches
$51.601 touches
Support (below)
$47.8823 touches
$46.891 touches
$45.5816 touches
Upside zones: $45.83 / $46.10 / $46.37
See all levels on the live chart →Insider and institutional activity
Insiders
Neutral30-day buys / sells
0 / 030-day net
—Hedge fund holders
0Latest SNY news and filings
- DealFiscal.ai
Sanofi to buy Vicebio and Dynavax in $3.4 billion deal
Sanofi is purchasing Vicebio and Dynavax, with the transaction valued at $3.4 billion. Both businesses will become part of Sanofi.
- DealFiscal.ai
Sanofi Pays MacroGenics $24.5 Million After Milestone
MacroGenics said Sanofi paid it $24.5 million tied to a milestone. The payment stems from the two drugmakers' existing agreement.
- DealFiscal.ai
Sanofi adds equity investment in Adagene trial
Sanofi has made a further equity investment tied to an Adagene trial. The move adds to Sanofi's existing financial backing of the study.
- AnalystFiscal.ai
UBS lifts its price target on Sanofi
UBS raised its price target for Sanofi. The change is an analyst update on the drugmaker's stock.
- AnalystFiscal.ai
BNP Paribas raises Sanofi rating to Outperform
BNP Paribas upgraded Sanofi's stock rating to Outperform. The change reflects the analyst's updated view of the company.
- AnalystFiscal.ai
AlphaValue/Baader Europe raises its price target on Sanofi
AlphaValue/Baader Europe increased its price target for Sanofi. The change is an analyst update and does not include a stated reason or new figure.
- AnalystFiscal.ai
AlphaValue/Baader Europe raises Sanofi rating to Add
AlphaValue/Baader Europe upgraded its rating on Sanofi to Add. The change reflects the firm's revised view of the drugmaker's shares.
Live SNY chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is SNY bullish or bearish today?
SNY daily trend: Downtrend (confirmed) — turns up above $40.315. SEPT signal: Institutional Drive (Strong Bullish). Updated Nov 15, 2026.
What is SNY's trend on each timeframe?
Daily: Downtrend (confirmed); 4 hour: Leaning Bearish; 1 hour: Bearish; 15 min: Bearish; 5 min: Leaning Bearish.
What are SNY support and resistance levels?
Support: $47.88, $46.89, $45.58. Resistance: $49.42, $50.60, $51.60. Last price $48.37.
Are insiders buying or selling SNY?
Insider signal: Neutral. Last 30 days: 0 buys, 0 sells.
What is the latest news on SNY?
Nov 13, 2026: Sanofi to buy Vicebio and Dynavax in $3.4 billion deal · Nov 13, 2026: Sanofi Pays MacroGenics $24.5 Million After Milestone · Nov 9, 2026: Sanofi adds equity investment in Adagene trial